• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C80-O20
Device Problems Hole In Material (1293); Leak/Splash (1354); Stretched (1601)
Patient Problem Failure of Implant (1924)
Event Date 10/16/2017
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent and a suprarenal aortic extension.On (b)(6) 2017 a routine follow up computed tomography (ct) showed the patient had a dilation of the suprarenal cuff and an out-pouching of the main body stent at the distal part of the device.There is also a suspected type 3b endoleak of the suprarenal aortic extension.The physician is planning to reline the initial devices with a non-endologix stent.A secondary procedure has not been completed or scheduled for this patient.The patient has been reported to be doing well and is currently in stable condition.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the clinical assessment was able to confirm a type 3b endoleak of the cuff and main body devices.Additionally a clinical evaluation was able to identify a dilation of the main body stent and refute the dilation of the suprarenal stent.The most likely cause of the type 3b endoleak of the cuff and main body was related to the use of strata material.There were no procedure related harms due to the lack of medical information surrounding both the implant and the event.To date the patient has not had a secondary procedure.The event devices remain implanted in the patient and were not available for further evaluation.The review of the manufacturing lot confirmed all devices met specifications prior to release.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7031225
MDR Text Key92020930
Report Number2031527-2017-00599
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2012
Device Model NumberA34-34/C80-O20
Device Lot NumberW11-4584-006
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/16/2017
Initial Date FDA Received11/14/2017
Supplement Dates Manufacturer Received01/15/2018
Supplement Dates FDA Received01/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/11/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age83 YR
-
-